Vastarel MR Tablets / Modified Release
Trimetazidine Dihydrochloride
35mg
Les Laboratoires Servier Industrie
| Pack size | 60's (30's Blister x 2) |
|---|---|
| Dispensing mode | POM |
| Source | FRANCE |
| Agent | Modern Pharmaceutical Co. |
| Retail Price | 62.50 AED |
Indications
Vastarel MR Tablets / Modified Release is used for:
Ischaemic heart disease, Angina pectoris, Coronary heart disease
Adult Dose
Oral
Angina pectoris
Adult: 40-60 mg daily in 2-3 divided doses.
Modified-release tab: 35 mg bid.
Child Dose
Renal Dose
Renal impairment:
CrCl (ml/min) Dosage Recommendation
<30 Contraindicated.
30-60 20 mg bid. Modified-release: 35 mg once daily.
Administration
Should be taken with food.
Contra Indications
Hypersensitivity to Trimetazidine Dihydrochloride.
Precautions
Moderate renal impairment (CrCl 30-60 mL/min). Pregnancy. Patient Counselling May cause dizziness and drowsiness, if affected, do not drive or operate machinery. Although teratological studies have not shown any drug related adverse effects on the course and outcome of pregnancy, the use in pregnant women is not recommended.
It is not known whetherTrimetazidine passes into breast milk or not. This medication should be used while breast feeding only if the potential benefits outweigh risks to the nursing infants.
Pregnancy-Lactation
Interactions
MAOIs, nifedipine. May potentiate the effects of other antianginals.
Adverse Effects
Side effects of Trimetazidine Dihydrochloride :
Dizziness, headache, abdominal pain, dyspepsia, diarrhoea, nausea, vomiting, pruritus, rash, urticaria, asthenia. Rarely, tachycardia, palpitations, extrasystoles, orthostatic hypotension, arterial hypotension, flushing.
Mechanism of Action
Trimetazidine is a cellular acting anti-ischaemic agent. It has 3 main properties by which it acts as a cytoprotective agent. It inhibits the anaerobic glycolysis and fatty acid metabolism, thus allowing only aerobic glycolysis. This action helps to restore the energy balance in the cell. It inhibits acidosis and free radical accumulation in the cell. All these action help the cell to restore the normal ionic and metabolic balance.
Note
Vastarel MR 35mg Tablets / Modified Release manufactured by Les Laboratoires Servier Industrie. Its generic name is Trimetazidine Dihydrochloride. Vastarel MR is availble in United Arab Emirates.
Farmaco UAE drug index information on Vastarel MR Tablets / Modified Release is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.